Patent · US Active

Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer

US10058591B2 · kind B2 · utility

2Cited by

1References

2Claims

0Family size

Assignees

Deutsches Krebsforschungszentrum · DE
RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

Zahari Raykov · Heidelberg, DE
Svitlana Grekova · Heidelberg, DE
Laurent Daeffler · Heidelberg, DE
Jean Rommelaere · Heidelberg, DE
Marc Aprahamian · Heidelberg, DE
Nathalia Giese · Schriesheim, DE

Key dates

Filing date	Dec 3, 2015
Grant date	Aug 28, 2018
Priority date	—
Expiry date	Dec 3, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a combination of a parvovirus and a cytokine, preferably IFNy, for use in treating pancreatic cancer, in particular a terminal stage of this disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.